MedTrace Logo

Study of MIGRA-ZEN RELIEF PLUS In the Treatment of Chronic Migraine Headache

NCT01135784 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-06-14

No results posted yet for this study

Summary

The purpose of this study is to study MIGRA-ZEN RELIEF PLUS, an all-natural herbal dietary supplement product, with respect to alleviating and/or stopping migraine headache pain compared to a placebo when used prophylactically. This study will involve subjects suffering from chronic migraine headaches.

Conditions

  • Chronic Migraine

Interventions

DIETARY_SUPPLEMENT

MIGRA-ZEN RELIEF PLUS

one 2-capsule dose per 24hrs for a total of 180 caps over 90 days

DIETARY_SUPPLEMENT

Placebo for Migrazen relief plus

2 capsule dose per 24 hours for 90 days

Sponsors & Collaborators

  • RZN Nutraceuticals, Inc.

    lead INDUSTRY

Principal Investigators

  • Amnon Mosek, MD · Saurasky Tel Aviv Medical Center, Israel

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-06-30
Completion
2012-07-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01135784 on ClinicalTrials.gov